| Rita Kay Ham, LMHP | |
|
835 S Burlington Ave, Suite 108, Hastings, NE 68901-6912 | |
| (402) 463-7711 | |
| (402) 461-5099 |
| Full Name | Rita Kay Ham |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 835 S Burlington Ave, Hastings, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104020718 | NPI | - | NPPES |
| 376 | Other | NE | ALCOHOL & DRUG COUNSELOR |
| 1011 | Other | NE | PROFESSIONAL COUNSELOR |
| 1671 | Other | NE | MENTAL HEALTH PRACTITIONE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 376 (Nebraska) | Primary |
| 101YM0800X | Counselor - Mental Health | 1671 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rita Kay Ham, LMHP 516 W F St, Hastings, NE 68901-6170 Ph: (402) 984-3334 | Rita Kay Ham, LMHP 835 S Burlington Ave, Suite 108, Hastings, NE 68901-6912 Ph: (402) 463-7711 |
News Archive
Lutheran Medical Center (LMC) and Medsphere Systems Corporation today announced the successful implementation of Medsphere's OpenVista® electronic health record (EHR) solution throughout the hospital. The full service 476-bed teaching hospital is now on track to achieve meaningful use and qualify for millions of dollars made available by the American Recovery and Reinvestment Act of 2009.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company specializing in products for cancer and supportive care, is presenting a scientific poster today at the Multinational Association of Supportive Care in Cancer Conference in Vancouver, B.C. The poster presentation, co-authored by Dr. David Nowotnik of Access Pharmaceuticals and Dr. Caroline Dumas of SpePharm Holdings, summarizes MuGard clinical experience from cancer patients globally undergoing radiotherapy and/or chemotherapy.
Researcher have reviewed the evidence showing the effects of the SARS-CoV-2 or novel coronavirus infection (COVID-19) on the cardiovascular system. Their study titled, "Potential Effects of Coronaviruses on the Cardiovascular System: A Review," was published in the latest issue of JAMA Cardiology.
Lung cancer patients given amrubicin (Calsed) as a second-line therapy had a significantly improved response rate and longer progression-free survival than patients treated with topotecan (Hycamtin), according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer.
› Verified 8 days ago
Cassandra Mohler, Counselor Medicare: Not Enrolled in Medicare Practice Location: 724 S Burlington Ave, Hastings, NE 68901 Phone: 402-463-7435 Fax: 402-463-0687 | |
Taylor Kindig, Counselor Medicare: Medicare Enrolled Practice Location: 225 N Saint Joseph Ave, Hastings, NE 68901 Phone: 402-463-5075 | |
Deneen Jane Denny, AAS,PLADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 907 S Kansas Ave, Hastings, NE 68901 Phone: 402-462-4677 | |
Amanda M Schroeder, PLMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 835 S Burlington Ave, Suite 108, Hastings, NE 68901 Phone: 402-463-7711 Fax: 402-461-5099 | |
Elizabeth Anne Spencer, MS ED, LIMHP, LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 432 N Minnesota Ave, Hastings, NE 68901 Phone: 402-463-1400 Fax: 402-463-1442 | |
Arlene Karr, Counselor Medicare: Not Enrolled in Medicare Practice Location: 724 S Burlington Ave, Hastings, NE 68901 Phone: 402-463-7435 | |
Lindsey Ann Lyons, PLADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 907 S Kansas Ave, Hastings, NE 68901 Phone: 402-462-4677 |